Cigna

iPMI Market Interviews

Interviews

iPMI Global Speaks with Chris Carter, CEO, ExpatInsure

The International Private Medical Insurance (IPMI) sector has long been defined by legacy giants, complex policy jargon and traditional corporate packages. As the modern expat demographic shifts towards digital nomads, independent professionals and micro-multinationals, the industry is being forced to rethink.  In this exclusive iPMI Global Interview, we sit down with Chris Carter, CEO of ExpatInsure, to discuss the company's growth, how it is using technology to strip the complexity out of buying cover, and why the model of the bloated...

18-06-2026 iPMI Global

Interviews

iPMI Global Speaks with Gitte Bach, CEO, New Frontier Group

iPMI Global, the leading business intelligence platform for the international private medical insurance (IPMI) and global assistance sectors, has officially released its latest executive round table report, titled "The Algorithmic Gatekeeper: AI and the Future of IPMI." Featuring crucial insights from New Frontier Group CEO Gitte Bach, “The Algorithmic Gatekeeper” maps the transition from manual administration to intelligent clinical navigation. A primary focal point of the round table is the critical necessity for "explainability" and human accountability as artificial intelligence begins to...

22-05-2026 iPMI Global

iPMI Market Providers

UK: Figures Reveal Real-Term Government Health Spending Fell by 2.1% Last Year

New figures from the Office for National Statistics (ONS) reveal that Government-financed healthcare spending was around £239bn in 2023 – a real-terms decrease of 2.1%. That seems to undermine the Government’s claim of ‘record funding’ last year, says a leading expert.

Dr Avinash Hari Narayanan (MBChB), Clinical Lead at London Medical Laboratory, says: ‘The ONS’ new “UK Health Accounts” report reveals Government-financed healthcare expenditure was around £239bn in 2023, a decrease of 2.1% after adjusting for inflation. Government healthcare expenditure also decreased by 0.7% in nominal terms and by 5.5% in real terms between 2021 and 2022. With the NHS proving to be one of the key voter concerns going into next month’s General Election, these figures are probably not what the Conservatives wanted to hear.

‘At the launch of the 2023 NHS England Mandate last June, the then-Health Secretary Steve Baker said: “The Government has made up to £14.1 billion available for health and social care over the next 2 years, on top of record funding to improve elective, urgent and emergency, and primary care performance.” That pledge does not seem to have been entirely achieved.

‘Of course, last year’s frightening inflation won’t have helped. In fact, total healthcare expenditure (both Government and private) increased by 5.6% in nominal terms in 2023 but decreased by 1.4% after adjusting for inflation. This was the second consecutive year of negative real terms healthcare spending growth following a 4% decrease in 2022.

‘Perhaps most concerning of all is the slump in spending on preventative care. This component represented around 8.2% of Government healthcare spending in 2022 compared with 14.1% in 2021. While a portion of this fall reflects the end of Covid measures, preventative care should be central to a national health policy for whichever party wins on 4 July.

‘While Government-financed healthcare expenditure fell in real terms, private “out of pocket” healthcare spending, which includes hospital treatments, medical goods and other health services and products, accounted for 13.8% of overall healthcare spending or £40bn in 2023. On top of that, voluntary health insurance was 2.5% of overall health spending, or around £7bn.

‘This is understandable. With real-term cuts in Government funding, private health spending – particularly on preventative health products – looks increasingly sensible. The fact that consumers are spending money on preventative healthcare items such as vitamins, supplements and off-the-shelf blood tests looks to be a prudent decision in the face of a reduction in Government health spending as a share of GDP.

‘For those concerned about easy access to healthcare, it’s useful to know that revolutionary new blood tests introduced in the last few years mean people have swift access to a vast array of information about their own health through a simple finger-prick test, which can even be taken in their own home.

iPMI Global Network Directory

iPMI Global Launches July 2026 Global Provider Network Directory to Streamline B2B Sourcing and Glob…

14-07-2026 Network Directory iPMI Global

iPMI Global, the preeminent business intelligence resource for the international medical insurance sector, today announced the official release of the July 2026 edition of its Global Provider Network Directory. This directory serves as a mission-critical infrastructure tool for senior executives navigating the increasingly complex landscape of global B2B healthcare sourcing. Engineered to function as the definitive online B2B buyer’s guide, the directory eliminates the friction inherent in international partnership identification, providing a standardized, high-impact framework for insurers, hospitals, assistance companies, and third-party administrators (TPAs).

iPMI Global Unveils June 2026 Provider Network Directory: The Authoritative B2B Guide for Internatio…

19-06-2026 Network Directory iPMI Global

iPMI Global, the leading provider of business intelligence for the International Private Medical Insurance (iPMI) sector, today announced the launch of the June 2026 edition of its Global Provider Network Directory. Serving as the definitive online B2B buyer’s guide, this resource is engineered to streamline the identification of global partnerships for insurers, hospitals, assistance companies, and third-party administrators. In an industry where "right place, right time" care delivery is critical, iPMI Global provides a high-impact solution for industry payers looking to expand their service capabilities. The directory centralizes comprehensive company intelligence, offering a single, authoritative platform for executives to navigate the complex international healthcare ecosystem and secure seamless global reach. Discover the June 2026 iPMI Global Provider Network Directory—the definitive B2B buyer's guide for international healthcare sourcing, partnership identification, and market intelligence.

Welcome To iPMI Global

iPMI Global is the leading business intelligence provider for international private medical and expatriate healthcare insurance markets worldwide. Due to the nomadic nature of the international private medical insurance (iPMI) market, iPMI Global is an internet based business intelligence  service for worldwide insurance and medical assistance professionals, who need to understand the impacts of insurance and healthcare policy, regulatory, and legislative developments.

For the past 15 years senior level business executives, in over 120 countries, rely on iPMI Global to stay 1 step ahead of the risk and on the inside track of international private medical insurance.

Covering business travellers, high net worth individuals, expatriate and leisure travel markets, iPMI Global is the only international news source covering the most exciting sector of international health insurance: international private medical insurance.

Socials